CV Lattes
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduate at Biomedicina from União das Faculdades Barão de Mauá (1997), master's at Applied Imunology from Universidade de São Paulo (2002) and ph.d. at Applied Imunology from Universidade de São Paulo (2006). Has experience in Immunology, focusing on Applied Imunology, acting on the following subjects: dna-hsp65, tuberculosis, dna vaccine, diabete and streptozotocina. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
In developing countries, tuberculosis (TB) remains one of the three most common fatal infectious diseases, along with acquired immune deficiency syndrome and malaria. The BCG vaccine protects against disseminated disease in childhood, but does not protect against adult pulmonary TB. A new vaccine against TB would need to induce protection superior to that elicited by the BCG vaccine and t…
| 1 / 1 | Completed research grants |
| 5 / 2 | Completed scholarships in Brazil |
| 6 / 3 | All research grants and scholarships |
| Associated processes | |